#CHAARTED2 - Twitter Hashtag

about 2 years ago

Watch an analysis of top abstracts from #ASCO24 in #GU #Cancer with experts Dr. Christian Kollmannsberger, @LuciaNappi4 and @navstruck. https://t.co/JszHahIlp8 #CHAARTED2 #TheMAST #EMBARK #CYCLONE2 #PSMAfore #CLEAR #KEYNOTE426 #IMmotion010 #GUCancer #MedOnc

OncEd's tweet photo. Watch an analysis of top abstracts from #ASCO24 in #GU #Cancer with experts Dr. Christian Kollmannsberger, @LuciaNappi4 and @navstruck.

https://t.co/JszHahIlp8

#CHAARTED2 #TheMAST #EMBARK #CYCLONE2 #PSMAfore #CLEAR #KEYNOTE426 #IMmotion010 #GUCancer #MedOnc https://t.co/HBIPnGUzBS

0

4

1

2

2K

GU Oncology Now @GUOncologyNow

about 2 years ago

📺 Check out our video with @koshkin85 and @ChrisKyriakoMD on the #CHAARTED2 trial, which evaluated #cabazitaxel with #abiraterone versus #abiraterone alone for #CRPC following #docetaxel. 👀 Watch Now: https://t.co/mSeg2TTKXO

0

7

1

0

396

UroToday.com

@urotoday

about 2 years ago

Cabazitaxel with abiraterone vs abiraterone alone - randomized trial for extensive disease following docetaxel: The #CHAARTED2 trial of the ECOG-ACRIN Cancer Research Group (EA8153) @ChrisKyriakoMD @UWCarbone. #ASCO24 coverage @zklaassen_md > https://t.co/pOqWVePIHZ @eaonc

urotoday's tweet photo. Cabazitaxel with abiraterone vs abiraterone alone - randomized trial for extensive disease following docetaxel: The #CHAARTED2 trial of the ECOG-ACRIN Cancer Research Group (EA8153) @ChrisKyriakoMD @UWCarbone. #ASCO24 coverage @zklaassen_md > https://t.co/pOqWVePIHZ @eaonc https://t.co/yoKrq29fHC

0

4

1

802

Jun Gong, MD @jgong15

about 2 years ago

Dr. Kyriakopoulos @UWCarbone rand PhII EA8153 ##CHAARTED2 #mCRPC prev treated w/ADT+doce 1:1 abi/cabazitaxel X6 vs abi/pred alone ➡️ superior PFS 14.9 vs 9.9 mos & improved PSA change w/combo. OS underpowered. More cytopenias w/combo arm (65.1% w/DR in combo) #ASCO24 @OncoAlert

jgong15's tweet photo. Dr. Kyriakopoulos @UWCarbone rand PhII EA8153 ##CHAARTED2 #mCRPC prev treated w/ADT+doce 1:1 abi/cabazitaxel X6 vs abi/pred alone ➡️ superior PFS 14.9 vs 9.9 mos & improved PSA change w/combo. OS underpowered. More cytopenias w/combo arm (65.1% w/DR in combo)

#ASCO24 @OncoAlert https://t.co/O8nV50hD0Y

0

12

10

1

1K

UroToday.com

@urotoday

about 2 years ago

Excited for Christos Kyriakopoulos to present on cabazitaxel with abiraterone vs abiraterone alone for extensive disease following docetaxel: The #CHAARTED2 trial of the @eaonc (EA8153) at #ASCO24! Critical insights ahead! #ProstateCancer #Oncology #ClinicalTrials @ASCO

urotoday's tweet photo. Excited for Christos Kyriakopoulos to present on cabazitaxel with abiraterone vs abiraterone alone for extensive disease following docetaxel: The #CHAARTED2 trial of the @eaonc (EA8153) at #ASCO24! Critical insights ahead! #ProstateCancer #Oncology #ClinicalTrials @ASCO https://t.co/jjnFa4w3yI

0

6

3

0

687

Top Tweets for #CHAARTED2

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users